Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Targeting Epigenetic Resistance Mechanisms to PI3 Kinase Inhibition in Leukemic Stem Cells

Shira Glushakow-Smith, Imit Kaur, Simone Sidoli, Shayda Hemmati, Ellen Angeles, Taneisha Sinclair, Aaliyah Battle, Amit Verma, Kira Gritsman

Blood (2023) 142 (Supplement 1): 1426.

https://doi.org/10.1182/blood-2023-186796

Published: 2023

Journal Articles

PI3-Kinase Deletion Dysregulates Autophagy in HSCs and Promotes Myelodysplasia

Kristina Ames, Imit Kaur, Shayda Hemmati, Shira Glushakow-Smith, Lindsay Meg Gurska, Yang Shi, Robert A Dubin, Jidong Shan, Kith Pradhan, Amit Verma, Cristina Montagna, Kira Gritsman

Blood (2021) 138 (Supplement 1): 323.

https://doi.org/10.1182/blood-2021-150655

Published: 2021

Journal Articles

Class I PI3K Is Required for HSC Differentiation

Kristina Ames, PhD, Imit Kaur, PhD, Meng Tong, Shayda Hemmati, PhD, Ellen Tein, Shira Glushakow-Smith, Lindsay Gurska, Kira Gritsman, MD PhD

Blood (2019) 134 (Supplement_1): 2461.

https://doi.org/10.1182/blood-2019-123823

Published: 2019

Journal Articles

PI3Kinase Alpha and Delta Promote Hematopoietic Stem Activation Under Stress

Shayda Hemmati, PhD, Taneisha Sinclair, Meng Tong, Boris Bartholdy, PhD, Rachel Okabe, MD, Kristina Ames, PhD, Leanne Ostrodka, MD, Tamanna Haque, MD, Imit Kaur, PhD, Anupriya Agarwal, PhD, Jean Zhao, PhD, Thomas Roberts, PhD, Kira Gritsman, MD PhD

Blood (2018) 132 (Supplement 1): 329.

https://doi.org/10.1182/blood-2018-99-114891

Published: 2018

Journal Articles

The Nitric Oxide-Generating Prodrug Js-K Reverses the Multi-Drug Resistance Phenotype in AML Cells

Stephan Morys, BS, Catherine Gannage, Moises Terrazas, MS, Imit Kaur, PhD, Ken M Kosak, BS, Paul J Shami, MD

Blood (2016) 128 (22): 5127.

https://doi.org/10.1182/blood.V128.22.5127.5127

Published: 2016

Journal Articles

The Class IA PI3 Kinase Isoforms Have Distinct but Overlapping Roles in Adult Hematopoiesis

Kira Gritsman, MD PhD, Imit Kaur, PhD, Taneisha Sinclair

Blood (2015) 126 (23): 3587.

https://doi.org/10.1182/blood.V126.23.3587.3587

Published: 2015

NARROW

Targeting Epigenetic Resistance Mechanisms to PI3 Kinase Inhibition in Leukemic Stem Cells

PI3-Kinase Deletion Dysregulates Autophagy in HSCs and Promotes Myelodysplasia

Class I PI3K Is Required for HSC Differentiation

PI3Kinase Alpha and Delta Promote Hematopoietic Stem Activation Under Stress

The Nitric Oxide-Generating Prodrug Js-K Reverses the Multi-Drug Resistance Phenotype in AML Cells

The Class IA PI3 Kinase Isoforms Have Distinct but Overlapping Roles in Adult Hematopoiesis

Email alerts

ASH Publications

American Society of Hematology

Targeting Epigenetic Resistance Mechanisms to PI3 Kinase Inhibition in Leukemic Stem Cells

PI3-Kinase Deletion Dysregulates Autophagy in HSCs and Promotes Myelodysplasia

Class I PI3K Is Required for HSC Differentiation

PI3Kinase Alpha and Delta Promote Hematopoietic Stem Activation Under Stress

The Nitric Oxide-Generating Prodrug Js-K Reverses the Multi-Drug Resistance Phenotype in AML Cells

The Class IA PI3 Kinase Isoforms Have Distinct but Overlapping Roles in Adult Hematopoiesis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only